Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

Wed, 01st Sep 2021 19:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Power Metal Resources PLC - gold and base metals explorer with assets in North America, Australia and Africa - Identifies a "bullseye" geophysical anomaly at the First Development Resources Pty Ltd copper-gold projects in Australia which Power Metal is in the process of buying. A phase 1 work programme is now being finalised, and plans to list a UK holding company for the assets, FDR UK, are continuing.

----------

Greatland Gold PLC - gold explorer in Australia - Reports preliminary results from the 2021 drilling programme at the Juri joint venture in the Paterson province, Western Australia. The first four of nine holes show gold mineralisation. The results from the remaining holes are expected in October. A ground electromagnetic survey is due to start this month. "Intercepting gold mineralisation from our initial assays is an excellent result. Greatland will now recalibrate our Juri JV targets based on this initial information as well as the assays pending from the five remaining drill holes and combined with the new proposed ground EM survey," Chief Executive Shaun Day says.

----------

Galileo Resources PLC - London-based gold and base metals explorer - Amends deal to sell the Kalahari Copper Belt licences to Sandfire Resources Ltd, extending the long stop date to September 15. The extension will give the companies time to obtain ministerial consent. All other conditions for the sale have been met.

----------

Mirriad Advertising PLC - London-based advertising technology - Signs partnership agreement with Looping Group, a German advertising agency. The two companies will develop and introducer plan covering prospective clients. Mirriad will bring its services to Looping's clients including Mercedes-Benz, Allianz SE and Deutsche Telekom AG.

----------

Seed Innovations Ltd - investor in pharmaceutical companies - Notes that portfolio company Little Green Pharma Ltd, in which Seed owns 3.1%, released its results for the financial year ended June 30. LGP made AUD7.0 million revenue, equivalent to GBP3.7 million. LGP made pretax profit of AUD24.6 million, reflecting an uplift to the value of a facility in Denmark.

----------

BP Marsh & Partners PLC - investor in financial services companies - MB Prestige Holdings Pty Ltd is sold to ATC Insurance Solutions Pty Ltd for AUD17 million, around GBP9 million. BP Marsh agrees to swap its 40% stake in MB Prestige for newly issued ATC Insurance shares. As a result, BP Marsh's stake in ATC Insurance will increase to 26% from 20%. The transaction represents a 20% uplift in BP Marsh's latest published valuation of its MB Prestige stake on January 31, of AUD5.7 million.

----------

Semper Fortis Esports PLC - London-based esports teams operator - Signs 20-year-old Thibault Grzesiak for the SMPR Rocket League team. The team is now complete and ready for the new season. Financial terms of the deal are not disclosed.

----------

Tissue Regenix Group PLC - Leeds-based wound treatment products - Launches two new products, DermaPure Meshed and VNEW, both line extensions to the biosurgery division. DermaPure meshed provides surgeons with a customised option that eliminates manual meshing in the operating room. VNEW is a pre-shaped, pre-cut acellular dermal allograft. Tissue Regenix has already fulfilled its initial stocking order for VNEW.

----------

Riverstone Credit Opportunities Income PLC - investor in debt - Invests USD12.5 million in a USD100.0 million first lien green term loan to a polyethylene recycling company. The loan matures in August 2024 and has an expected all-in yield to maturity of 13.5%. This is Riverstone Credit's first green loan, and it plans to use similar lending structures in future.

----------

Vaalco Energy Inc - Houston-based oil producer in Gabon and Equatorial Guinea - Agreements with World Carrier Offshore Services Corp are now effective after joint venture partners approve. Last Thursday, Vaalco announced the deals to rent a floating storage and offloading unit at the Etame Marin Field in Gabon.

----------

Altus Strategies PLC - mining royalties investor - Drilling confirms the discovery of a significant zone of gold mineralisation at the Tabakorole project in Mali. Altus holds a 49% stake and 2.5% net smelter return on Tabakorole. The results are expected to increase the volume and grade of the mineral resource estimate.

----------

Diurnal Group PLC - Cardiff-based hormone drug developer - Launches Efmody, a treatment for congenital adrenal hyperplasia, in Germany and Austria. Pricing is in line with the company's expectations. Diurnal is in talks with health authorities across the European Economic Area for further launches.

----------

Instem PLC - Staffordshire-based healthcare software - Buys Basel, Switzerland-based life sciences software company PDS Pathology Data Systems Ltd for a total enterprise value of CH14.3 million, around GBP11.4 million, in cash and shares. The deal will deepen Instem's relationship with some of its largest clients and be immediately earnings-enhancing, Instem says.

----------

TomCo Energy PLC - oil explorer in Utah - Amends terms of the deal to buy Tas Sands Holdings II LLC. TomCo now has until October 1 to exercise its right to buy an initial 10% of Tar Sands for USD2 million, extended from September 1. TomCo paid a USD100,000 deposit for the extension.

----------

MetalNRG PLC - investor in energy and precious metals projects - 50%-owned joint venture BritNRG is now profitable following operational improvements in the first half of 2021. The venture is producing 3,500 barrels of oil per month, versus less than 1,500 barrels per month in the first quarter. BritNRG sold 3,780 barrels in July at an average price of USD73.88 each. Revenue from the Whisby site is forecast to be over USD2.5 million per year.

----------

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

Monday 17 October 
Arcontech Group PLCAGM
Barratt Developments PLCAGM
Eight Capital Partners PLCGM re IWEP loan conversion to equity
Tuesday 18 October 
Accrol Group Holdings PLCAGM
Diverse Income TrustAGM
Dolphin Capital Investors LtdAGM
Pantheon International PLCAGM
Tlou Energy LtdAGM
Wednesday 19 October 
Empyrean Energy PLCGM annual report approval
Frasers Group PLCAGM
Hargreaves Lansdown PLCAGM
HydrogenOne Capital Growth PLCGM share issuance programme
Made Tech Group PLCAGM
SME Credit Realisation Fund LtdAGM
Thursday 20 October 
abrdn UK Smaller Companies Growth Trust PLCAGM
Argo Group LtdAGM
Dechra Pharmaceuticals PLCAGM
DX Group PLCGM re 2021 financial year annual report
Gateley Holdings PLCAGM
Science in Sport PLCGM 
Xeros Technology Group PLCGM capital reorganisation
Friday 21 October 
Diurnal Group PLCGM re Neurocrine takeover
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hyperplasia.

Read more
7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommended its 'Efmody' hydrocortisone modified-release hard capsules as an option for restricted use to treat adolescents and adults with congenital adrenal hyperplasia (CAH) within NHS Wales.

Read more
14 Sep 2022 11:40

Diurnal annual loss widens despite revenue growth as costs balloon

(Alliance News) - Diurnal Group PLC on Wednesday reported a widened annual loss as costs, especially on research & development, surged.

Read more
7 Sep 2022 15:53

UK earnings, trading statements calendar - next 7 days

Thursday 8 September 
Arecor Therapeutics PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Chaarat Gold Holdings LtdHalf Year Results
Curtis Banks Group PLCHalf Year Results
Darktrace PLCFull Year Results
Destiny Pharma Holdings PLCHalf Year Results
Duke Royalty LtdFull Year Results
Emis Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
International Public Partnerships LtdHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
M Winkworth PLCHalf Year Results
Oakley Capital Investments LtdHalf Year Results
Open Orphan PLCHalf Year Results
Restaurant Group PLCHalf Year Results
Safestore Holdings PLCQ3 Results
Severfield PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
SourceBio International PLCHalf Year Results
Spire Healthcare Group PLCHalf Year Results
Sylvania Platinum LtdFull Year Results
Vistry Group PLCHalf Year Results
Friday 9 September 
Computacenter PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Mid Wynd International Investment Trust PLCFull Year Results
Monday 12 September 
ABCAM PLCHalf Year Results
Arcontech Group PLCFull Year Results
Associated British Foods PLCFull Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Made Tech Group PLCFull Year Results
MP Evans Group PLCHalf Year Results
SigmaRoc PLCHalf Year Results
Tirupati Graphite PLCFull Year Results
Tuesday 13 September 
accesso Technology Group PLCHalf Year Results
Churchill China PLCHalf Year Results
Corero Network Security PLCHalf Year Results
Engage XR Holdings PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Fevertree Drinks PLCHalf Year Results
Futura Medical PLCHalf Year Results
Gateley Holdings PLCFull Year Results
Harworth Group PLCHalf Year Results
HeiQ PLCHalf Year Results
JTC PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCHalf Year Results
Petra Diamonds LtdFull Year Results
Property Franchise Group PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Wednesday 14 September 
Anpario PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
Tullow Oil PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 14:55

Diurnal to be taken over by Neurocrine Biosciences for £48.3m, shares surge

(Sharecast News) - Diurnal shares surged on Tuesday after it agreed to be taken over by US biotech firm Neurocrine Biosciences for £48.3m.

Read more
30 Aug 2022 12:47

Diurnal shares double on GBP48 million takeover from Neurocrine

(Alliance News) - Diurnal Group PLC on Tuesday said it agreed to a GBP48.3 million takeover from US biopharmaceutical firm Neurocrine Biosciences Inc.

Read more
30 Aug 2022 11:04

AIM WINNERS & LOSERS: Diurnal shares more than double on takeover bid

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
26 Jul 2022 12:03

IN BRIEF: Diurnal more than doubles product sales in 2022

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says product sales in the year ended June 30, more than doubled to GBP4.6 million from GBP2.3 million the previous year. Revenue in the year totals GBP4.7 million including licensing income of GBP600,000, up from GBP4.4 million the previous year, including licensing income of GBP2.1 million.

Read more
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
9 May 2022 14:01

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

Read more
25 Apr 2022 19:19

IN BRIEF: Diurnal expands distribution agreement with EffRx

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Extends distribution and marketing agreement with EffRx Pharmaceuticals in Switzerland to include Efmody.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.